OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma
Ulrich Wahn, Claus Bachert, Joachim Heinrich, et al.
Allergy (2018) Vol. 74, Iss. 3, pp. 594-604
Open Access | Times Cited: 115
Ulrich Wahn, Claus Bachert, Joachim Heinrich, et al.
Allergy (2018) Vol. 74, Iss. 3, pp. 594-604
Open Access | Times Cited: 115
Showing 1-25 of 115 citing articles:
Allergen Immunotherapy in Children User’s Guide
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 269
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 269
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
Ioana Agache, Cezmi A. Akdiş
Journal of Clinical Investigation (2019) Vol. 129, Iss. 4, pp. 1493-1503
Open Access | Times Cited: 257
Ioana Agache, Cezmi A. Akdiş
Journal of Clinical Investigation (2019) Vol. 129, Iss. 4, pp. 1493-1503
Open Access | Times Cited: 257
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 225
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 225
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
Heimo Breiteneder, Yaqi Peng, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3039-3068
Open Access | Times Cited: 197
Heimo Breiteneder, Yaqi Peng, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3039-3068
Open Access | Times Cited: 197
Advances and highlights in biomarkers of allergic diseases
İsmail Öğülür, Yağız Pat, Özge Ardıçlı, et al.
Allergy (2021) Vol. 76, Iss. 12, pp. 3659-3686
Open Access | Times Cited: 150
İsmail Öğülür, Yağız Pat, Özge Ardıçlı, et al.
Allergy (2021) Vol. 76, Iss. 12, pp. 3659-3686
Open Access | Times Cited: 150
Advances and recent developments in asthma in 2020
Lacin Cevhertas, İsmail Öğülür, Debbie J. Maurer, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3124-3146
Open Access | Times Cited: 149
Lacin Cevhertas, İsmail Öğülür, Debbie J. Maurer, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3124-3146
Open Access | Times Cited: 149
Mechanisms of allergen-specific immunotherapy and allergen tolerance
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 139
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 139
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
The Lancet Regional Health - Europe (2021) Vol. 13, pp. 100275-100275
Open Access | Times Cited: 104
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
The Lancet Regional Health - Europe (2021) Vol. 13, pp. 100275-100275
Open Access | Times Cited: 104
Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023
Marek Lommatzsch, Carl-Peter Criée, Carmen C.M. de Jong, et al.
Pneumologie (2023) Vol. 77, Iss. 08, pp. 461-543
Open Access | Times Cited: 43
Marek Lommatzsch, Carl-Peter Criée, Carmen C.M. de Jong, et al.
Pneumologie (2023) Vol. 77, Iss. 08, pp. 461-543
Open Access | Times Cited: 43
Perspectives in allergen immunotherapy: 2019 and beyond
Oliver Pfaar, Ioana Agache, F. de Blay, et al.
Allergy (2019) Vol. 74, Iss. S108, pp. 3-25
Open Access | Times Cited: 128
Oliver Pfaar, Ioana Agache, F. de Blay, et al.
Allergy (2019) Vol. 74, Iss. S108, pp. 3-25
Open Access | Times Cited: 128
Advances and novel developments in allergic rhinitis
Yifan Meng, Chengshuo Wang, Luo Zhang
Allergy (2020) Vol. 75, Iss. 12, pp. 3069-3076
Open Access | Times Cited: 123
Yifan Meng, Chengshuo Wang, Luo Zhang
Allergy (2020) Vol. 75, Iss. 12, pp. 3069-3076
Open Access | Times Cited: 123
Real‐world evidence of subcutaneous allergoid immunotherapy in house dust mite‐induced allergic rhinitis and asthma
Marek Jutel, Bernd Brüggenjürgen, Hartmut Richter, et al.
Allergy (2020) Vol. 75, Iss. 8, pp. 2050-2058
Open Access | Times Cited: 70
Marek Jutel, Bernd Brüggenjürgen, Hartmut Richter, et al.
Allergy (2020) Vol. 75, Iss. 8, pp. 2050-2058
Open Access | Times Cited: 70
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies
Mariana Farraia, Inês Paciência, Francisca de Castro Mendes, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1719-1735
Open Access | Times Cited: 53
Mariana Farraia, Inês Paciência, Francisca de Castro Mendes, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1719-1735
Open Access | Times Cited: 53
Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
House dust mite SCIT reduces asthma risk and significantly improves long‐term rhinitis and asthma control—A RWE study
Marek Jutel, Ludger Klimek, Hartmut Richter, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 1042-1051
Open Access | Times Cited: 10
Marek Jutel, Ludger Klimek, Hartmut Richter, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 1042-1051
Open Access | Times Cited: 10
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)
P. Démoly, Mathiéu Molimard, Jean‐François Bergmann, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100915-100915
Open Access | Times Cited: 9
P. Démoly, Mathiéu Molimard, Jean‐François Bergmann, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100915-100915
Open Access | Times Cited: 9
Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy
Tadech Boonpiyathad, Milena Sokołowska, Hideaki Morita, et al.
Allergy (2018) Vol. 74, Iss. 5, pp. 976-985
Closed Access | Times Cited: 80
Tadech Boonpiyathad, Milena Sokołowska, Hideaki Morita, et al.
Allergy (2018) Vol. 74, Iss. 5, pp. 976-985
Closed Access | Times Cited: 80
The role of Treg cell subsets in allergic disease
Tadech Boonpiyathad, Zeynep Çelebi Sözener, Mübeccel Akdiş, et al.
Asian Pacific Journal of Allergy and Immunology (2019)
Open Access | Times Cited: 74
Tadech Boonpiyathad, Zeynep Çelebi Sözener, Mübeccel Akdiş, et al.
Asian Pacific Journal of Allergy and Immunology (2019)
Open Access | Times Cited: 74
Towards definitive management of allergic rhinitis: best use of new and established therapies
Lubnaa Hossenbaccus, Sophia Linton, Sarah Garvey, et al.
Allergy Asthma and Clinical Immunology (2020) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Lubnaa Hossenbaccus, Sophia Linton, Sarah Garvey, et al.
Allergy Asthma and Clinical Immunology (2020) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Recent developments and highlights in allergen immunotherapy
Oliver Pfaar, Hongfei Lou, Yuan Zhang, et al.
Allergy (2018) Vol. 73, Iss. 12, pp. 2274-2289
Closed Access | Times Cited: 66
Oliver Pfaar, Hongfei Lou, Yuan Zhang, et al.
Allergy (2018) Vol. 73, Iss. 12, pp. 2274-2289
Closed Access | Times Cited: 66
Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 55
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 55
Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3584-3592
Open Access | Times Cited: 35
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3584-3592
Open Access | Times Cited: 35
